AstraZeneca

AstraZeneca is a pharmaceutical company that develops and commercializes prescription medicines for the treatment of cancer and heart diseases. Read more

97,432 Followers on Owler
97,432 Followers on Owler
97,432 Followers on Owler
97,432 Followers on Owler

AstraZeneca

AstraZeneca is a pharmaceutical company that develops and commercializes prescription medicines for the treatment of cancer and heart diseases. Read more

Pascal Soriot's photo - CEO of AstraZeneca

CEO

Pascal Soriot

CEO Approval Rating

70/100

Founded:

1999

Status:

PublicIndependent CompanyNYSEAZN

ASTRAZENECA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Pfizer has been one of AstraZeneca's top competitors. Pfizer is a Public company that was founded in 1849 in New York, New York. Like AstraZeneca, Pfizer also competes in the Pharmaceuticals sector. Compared to AstraZeneca, Pfizer has 18,800 more employees.

GSK is seen as one of AstraZeneca's biggest rivals. GSK is a Public company that was founded in Middlesex, England in 2000. Like AstraZeneca, GSK also operates in the Pharmaceuticals sector. GSK has 34,366 more employees vs. AstraZeneca.

Gilead is perceived as one of AstraZeneca's biggest rivals. Gilead was founded in Foster City, California} in 1987. Like AstraZeneca, Gilead also competes in the Pharmaceuticals space. Compared to AstraZeneca, Gilead generates $9.2B less revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is TEVA a competitor of AstraZeneca?

AstraZeneca Quarterly and Annual Revenue

Coming soon for AstraZeneca!

Annual Revenue

$33.9B

AstraZeneca's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 33.8B.

AstraZeneca Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Alexion Pharmaceuticals, Inc.

Dec 2020

Source »
$39B
Alexion develops and commercializes immunoregulatory drugs for the treatment of autoimmune and cardiovascular diseases.

-

Priority Review Voucher, US Food and Drug Administration

Aug 2019

Source »
$95M
-
Acerta Pharma

Dec 2015

Source »
$4B
Acerta Pharma discovers and develops drugs for oncology and autoimmune diseases.

-

Respiratory Business, Takeda Pharmaceutical Company Limited

Dec 2015

Source »
$575M
-
ZS Pharma, Inc.

Nov 2015

Source »
$2.7B
ZS Pharma develops and commercializes non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.

These are all the companies that AstraZeneca has acquired. AstraZeneca has acquired 15 companies and its latest acquisition was Alexion Pharmaceuticals, Inc. in Dec 2020. Alexion develops and commercializes immunoregulatory drugs for the treatment of autoimmune and cardiovascular diseases.

AstraZeneca Funding History

No recent funding data found related to AstraZeneca

AstraZeneca Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Innate Pharma is a biotechnology firm that develops and commercializes therapeutic antibodies for the treatment of cancer and inflammatory diseases.
$71.9M
Oct 22, 2018
Corporate Round
Nov 01, 2006
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
$34M
Sep 04, 2018
Series D
Oct 27, 2018
Rani Therapeutics is a biotechnology company that develops pills for the oral delivery of biologic drugs to treat patients with chronic diseases.
$53M
Feb 07, 2018
Series D
-
PhaseBio is a biopharmaceutical firm that researches and develops novel therapeutics for the treatment of orphan diseases.
$1.5M
Nov 29, 2017
Convertible Note
Oct 27, 2018
ADC Therapeutics develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers.
$200M
Oct 22, 2017
Series E
May 15, 2020

These are all the companies that AstraZeneca has invested in. AstraZeneca has invested 15 companies and its latest investment was Alexion Pharmaceuticals, Inc. in Dec 2020. Alexion develops and commercializes immunoregulatory drugs for the treatment of autoimmune and cardiovascular diseases.

AstraZeneca News

May 5, 2021Bangkok Post

Canada's Alberta confirms death linked to AstraZeneca vaccine

BENGALURU: The Canadian province of Alberta reported its first death of a patient from a rare blood c... See more »
May 5, 2021FE Investegate

Farxiga approved in the US for CKD

7:00 AM: (AZN) Farxiga approved in the US for CKD... See more »
May 4, 2021BorneoPost Online

MOH gives assurance of immediate treatment if blood clots occur

PUTRAJAYA (May 4): The Health Ministry (MOH) will constantly monitor the incidence of blood clots wit... See more »
May 3, 2021FierceBiotech

AstraZeneca's cancer R&D exec Fert joins Relay to run its lead asset as another bluebird exec jumps ship

AstraZeneca's cancer R&D exec Ferté joins Relay to run its lead asset as another bluebird exec jumps ... See more »
May 3, 2021ChinaPulse

Malaysia makes AstraZeneca Covid-19 vaccine optional amid safety fears, SE Asia News & Top Stories

KUALA LUMPUR (REUTERS) - Malaysia will begin a parallel Covid-19 innoculation programme this week for... See more »
May 3, 2021The Sydney Morning Herald

CSL open to new manufacturing options after AstraZeneca production

The biotech giant says it can hit the 50 million dose mark by December and is in talks with the gover... See more »

AstraZeneca Press Releases

March 30, 2021PR-Inside

The Law Offices of Vincent Wong Reminds ...

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / March 29, 2021 / The Law Offices of Vincent Wong announce... See more »
March 29, 2021NewsFile

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - March 29, 2021) - The Schall Law Firm, a national sharehol... See more »
March 26, 2021PR-Inside

Pomerantz Law Firm Reminds Shareholders with Losses ...

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / March 25, 2021 / Pomerantz LLP announces that a class act... See more »
March 23, 2021O'Dwyer's PR News

AstraZeneca Gets Science Right, Screws Up PR

AstraZeneca apparently got the science right in producing a COVID-19 vaccine in record time. It screw... See more »
March 21, 2021NewsFile

Astrazeneca Update

New York, New York--(Newsfile Corp. - March 21, 2021) - Faruqi & Faruqi, LLP, a leading national secu... See more »
March 19, 2021centralcharts

After AstraZeneca back-and-forth, authorities could struggle to convince sceptics

Experts fear mixed messaging over AstraZeneca's coronavirus jab could undermine public trust and slow... See more »
March 13, 2021GlobalNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline - AZN

NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, ... See more »

AstraZeneca Videos

Social Media

AstraZeneca Headquarters

1 Francis Crick Avenue Cambridge Biomedical Campus

Cambridge, EnglandCB2 0RE

44-20-7604-8000

Driving Directions »

Trending Companies

AstraZeneca Summary

ABOUT

Overview

AstraZeneca UK Limited (LON: AZN) develops pharmaceutical solutions for cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. It discovers new medicines that are designed to improve the health and quality of ...

CEO

AstraZeneca's CEO, Pascal Soriot, currently has an approval rating of 70%. AstraZeneca's primary competitors are Pfizer, GSK & Gilead.

Website

astrazeneca.com

Frequently Asked Questions about AstraZeneca

  1. When was AstraZeneca founded?

    AstraZeneca was founded in 1999
  2. Who is AstraZeneca's CEO?

    AstraZeneca's CEO is Pascal Soriot
  3. How much revenue does AstraZeneca generate?

    AstraZeneca generates $33.9B in revenue
  4. How much funding does AstraZeneca have?

    AstraZeneca has historically raised $0 in funding
  5. Where is AstraZeneca's headquarters?

    AstraZeneca's headquarters is in Cambridge England, GB
  1. How many employees does AstraZeneca have?

    AstraZeneca has 59,700 employees
  2. What sector does AstraZeneca operate in?

    AstraZeneca is in Pharmaceuticals, Biotechnology
  3. Who are AstraZeneca's competitors?

    AstraZeneca's top competitors are Pfizer, GSK, Gilead
  4. Who has AstraZeneca invested in?

    AstraZeneca's has invested in companies such as Innate Pharma, PhaseBio, Rani Therapeutics